Your search for proton pump inhibitor returned 12 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mpr-drug-news remove
MPR First Report remove

Your search for proton pump inhibitor returned 12 results

Sort Results:

Relevant Recent
AIBD 2019

PPI Use and Periodontal Disease: What’s the Link?

“The data indicate that more conservative periodontal therapy might initially be considered for IBD patients with advanced periodontal disease for whom PPI are prescribed as a component of their IBD treatment,” the authors concluded.

Long-Term PPI Use Discouraged for HIV-1-Infected Patients

Long-term use of proton pump inhibitors (PPIs) might increase microbial translocation and innate immune activation but not enterocyte turnover or T-cell activation among people infected with HIV-1, according to research findings reported at IDWeek 2016.
AASLD 2016

LDV/SOF ± RBV, OPrD Effective in HIV/HCV Co-Infected Veterans

Ledipasvir/Sofosbuvir with or without ribavirin is associated with comparable sustained virologic response (SVR) rates for African American patients and non-African Americans who have HIV/HCV co-infection, but cirrhosis was associated with significantly poorer rates.
AASLD 2016

Does Concomitant PPI Use Affect Efficacy of Elbasvir/Grazoprevir?

Consistent concomitant use of proton pump inhibitors (PPIs) with elbasvir/grazoprevir (EBR/GZR) had no clinically significant effect on 12-week sustained viral response (SVR12) rates in patients with hepatitis C virus (HCV) genotype (GT)1 or GT4 infection with and without cirrhosis, according to research presented at The Liver Meeting® 2016